One stop for all your health tips

I Did Red Light Therapy for 3 Months So You Didn’t Have To
I Did Red Light Therapy for 3 Months So You Didn’t Have To
Real Talk on Dating and Relationships ❤️
Real Talk on Dating and Relationships ❤️
The Insanely Difficult Standards of History’s Hardest P.E. Program
The Insanely Difficult Standards of History’s Hardest P.E. Program
MENS HEALTH FITS. ALL RIGHTS RESERVED.

6

May , 2024
New influenza vaccine strategies aim to enhance protection with T-cell responses
Tag: CD4

New influenza vaccine strategies aim to enhance protection with T-cell responses

In a recent review published in the journal Nature Reviews Immunology, researchers discussed the limitations of current influenza vaccines and the potential for future vaccines to induce both T-cell responses and antibodies for enhanced protection. They examined the strategies to develop influenza vaccines with broad strain specificity and long-term efficacy, covering protection requirements, immune response […]

7

Jan , 2024
Researchers identify mechanism that causes gastrointestinal problems with cancer immunotherapy
Tag: CD4

Researchers identify mechanism that causes gastrointestinal problems with cancer immunotherapy

Researchers at the University of Michigan Health Rogel Cancer Center have identified a mechanism that causes severe gastrointestinal problems with immune-based cancer treatment. They also found a way to deliver immunotherapy’s cancer-killing impact without the unwelcome side effect. The findings are published in Science. This is a good example of how understanding a mechanism […]

12

Aug , 2023
Salk scientists find new immunotherapy treatment for glioblastoma
Tag: CD4

Salk scientists find new immunotherapy treatment for glioblastoma

Glioblastoma, the most common and deadly form of brain cancer, grows rapidly to invade and destroy healthy brain tissue. The tumor sends out cancerous tendrils into the brain that make surgical tumor removal extremely difficult or impossible. Now, Salk scientists have found the immunotherapy treatment anti-CTLA-4 leads to considerably greater survival of mice with glioblastoma. […]